C Inagaki - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C Inagaki

Showing results (121-130 of 123) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 123 results.

ESMO Gastrointestinal Oncology|March 5, 2026

A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagiaY Nagata, H Arai, N Izawa, et al.

ESMO Open|January 3, 2026

Corrigendum to "A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)": [ESMO Open. Volume 10, Issue 9, (September 2025) 105571]M Wakabayashi, H Taniguchi, A Makiyama, et al.

ESMO Open|August 29, 2025

A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)M Wakabayashi, H Taniguchi, A Makiyama, et al.

Pageof 13

Search research articles

Showing results (121-130 of 123) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 123 results.

ESMO Gastrointestinal Oncology|March 5, 2026

A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagiaY Nagata, H Arai, N Izawa, et al.

ESMO Open|January 3, 2026

ESMO Open|August 29, 2025

A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)M Wakabayashi, H Taniguchi, A Makiyama, et al.

Pageof 13